Abstract:BACKGROUND: Hepatic stellate cells (HSCs) are the key effector cells mediating the occurrence and development of liver fibrosis, while aerobic glycolysis is an important metabolic characteristic of HSC activation. Transforming growth factor-β1 (TGF-β1) induces aerobic glycolysis and is a driving factor for metabolic reprogramming. The occurrence of glycolysis depends on a high glucose uptake level. Glucose transporter 1 (GLUT1) is the most widely distributed glucose transporter in the body and mainly participates in the regulation of carbohydrate metabolism, thus affecting cell proliferation and growth. However, little is known about the relationship between TGF-β1 and GLUT1 in the process of liver fibrosis and the molecular mechanism underlying the promotion of aerobic glycolysis in HSCs.AIM: To investigate the mechanisms of action of GLUT1, TGF-β1 and aerobic glycolysis in the process of HSC activation during liver fibrosis.METHODS: Immunohistochemical staining and immunofluorescence assays were used to examine GLUT1 expression in fibrotic liver tissue. A Seahorse extracellular flux (XF) analyzer was used to examine changes in aerobic glycolytic flux, lactate production levels and glucose consumption levels in HSCs upon TGF-β1 stimulation. The mechanism by which TGF-β1 induces GLUT1 protein expression in HSCs was further explored by inhibiting/promoting the TGF-β1/mothers-against-decapentaplegic-homolog 2/3 (Smad2/3) signaling pathway and inhibiting the p38 and phosphoinositide 3-kinase (PI3K)/AKT signaling pathways. In addition, GLUT1 expression was silenced to observe changes in the growth and proliferation of HSCs. Finally, a GLUT1 inhibitor was used to verify the in vivo effects of GLUT1 on a mouse model of liver fibrosis.RESULTS: GLUT1 protein expression was increased in both mouse and human fibrotic liver tissues. In addition, immunofluorescence staining revealed colocalization of GLUT1 and alpha-smooth muscle actin proteins, indicating that GLUT1 expression was related to the development of liver fibrosis. TGF-β1 caused an increase in aerobic glycolysis in HSCs and induced GLUT1 expression in HSCs by activating the Smad, p38 MAPK and P13K/AKT signaling pathways. The p38 MAPK and Smad pathways synergistically affected the induction of GLUT1 expression. GLUT1 inhibition eliminated the effect of TGF-β1 on HSC proliferation and migration. A GLUT1 inhibitor was administered in a mouse model of liver fibrosis, and GLUT1 inhibition reduced the degree of liver inflammation and liver fibrosis.CONCLUSION: TGF-β1 induces GLUT1 expression in HSCs, a process related to liver fibrosis progression. In vitro experiments revealed that TGF-β1-induced GLUT1 expression might be one of the mechanisms mediating the metabolic reprogramming of HSCs. In addition, in vivo experiments also indicated that the GLUT1 protein promotes the occurrence and development of liver fibrosis.

Hepatocyte nuclear factor 1α promotes glucose reabsorption of renal tubular epithelial cells by regulating glucose transporter 2

The Effect of Glucose Transporter 1 on Hexosamine Biosynthesis Pathway in Rat Glomerular Mesangial Cells

Ets1 Associates with KMT5A to Participate in High Glucose-Mediated EndMT Via Upregulation of PFN2 Expression in Diabetic Nephropathy.

Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice

Renal lipid accumulation induced by high-fat diet regulates glucose homeostasis via sodium-glucose cotransporter 2

Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium–Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice

Effects of High Levels of Glucose on the Expression of Adiponectin Receptors in Human Kidney Proximal Tubular Cells

Hepatocyte Nuclear Factor 4α Regulates the Expression of Pancreatic β-Cell Genes Implicated in Glucose Metabolism and Nutrient-induced Insulin Secretion

Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1α

Maintaining HNF6 Expression Prevents AdHNF3β-mediated Decrease in Hepatic Levels of Glut-2 and Glycogen

Kruppel Like Factor 5 Enhances High Glucose-Induced Renal Tubular Epithelial Cell Transdifferentiation in Diabetic Nephropathy.

Role of Hepatic Neuregulin 4 in the Regulation of Gluconeogenesis in Mice

Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells

Regulation of rat Na+/Pi cotransporter-1 gene expression: the roles of glucose and insulin.

Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.

SAT-155 OVEREXPRESSION OF NRF2 IN RENAL PROXIMAL TUBULAR CELLS STIMULATES SODIUM-GLUCOSE CO-TRANSPORTER 2 (sglt2) EXPRESSION IN DIABETIC TRANSGENIC MICE

Effect of angiotensin 1-7 on human renal proximal tubular epithelial cell transdifferentiation induced by high glucose and its mechanism

HIF-1 alpha Alleviates High-Glucose-Induced Renal Tubular Cell Injury by Promoting Parkin/PINK1-Mediated Mitophagy

Angiopoietin2-mediated caveolin1 phosphorylation regulating transcytosis of renal tubular epithelial cell contributes to the occurrence of albuminuria under high glucose exposure

Elevated Transcriptional Co-Activator P102 Mediates Angiotensin II Type 1 Receptor Up-Regulation and Extracellular Matrix Overproduction in the High Glucose-Treated Rat Glomerular Mesangial Cells and Isolated Glomeruli.

Effect of Mitofusin 2 Overexpression on the Proliferation and Apoptosis of High-Glucose-induced Rat Glomerular Mesangial Cells